Celularity Inc. Class A Common Stock (CELU) is a publicly traded Healthcare sector company. As of May 21, 2026, CELU trades at $0.89 with a market cap of $23.11M and a P/E ratio of -0.31. CELU moved +4.21% today. Year to date, CELU is -34.51%; over the trailing twelve months it is -64.58%. Its 52-week range spans $0.71 to $5.22. Rallies surfaces CELU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CELU financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CELU recently traded at $0.89. Market cap is $23.11M. P/E ratio is -0.31. Revenue is $54.22M.
| Metric | Value |
|---|---|
| Price | $0.89 |
| Market Cap | $23.11M |
| P/E Ratio | -0.31 |
| EPS | $-2.64 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.22 |
| 52-Week Low | $0.71 |
| Volume | 1.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $54.22M |
| Net Income | $-57.89M |
| Gross Margin | 72.36% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2024 | $54.22M | $-57.89M | $-2.64 |
| 2023 | $22.77M | $-196.29M | $-11.02 |
| 2022 | $17.98M | $14.19M | $0.10 |
| 2021 | $21.34M | $-100.12M | $0.00 |
CELU analyst coverage data. Average price target: $0.00.